Moreover, we found that the low expression of AKT3 in the exosomes of cancer tissues can lead to the reduction of CD4 + T cells and macrophage levels in the tumor microenvironment, further affecting the prognosis of CRC tumors and T, M, N, and stage, leading to accelerated cancer development and metastasis. This evidence concerns the gene AKT3 and neoplasm.